# Advanced Oncotherapy Plc Delivery of LIGHT

- Link: https://www.directorstalkinterviews.com/advanced-oncotherapy-plc-delivery-light/412725498
- Published: 2017-03-15T07:25:31+00:00
- Author: Giles Arbor

**[⌊Hardman & Co Report⌉⌊Hardman & Co Report⌉[Advanced Oncotherapy Plc** (LON:AVO)
is focused on delivering a more affordable, novel, proton-based radiotherapy system,
based on technology originally developed at the world renowned CERN. The company
is entering an exciting stage with construction work on its Harley Street site expected
to commence this month following preliminary assessment work. Meanwhile, individual
modules for the LIGHT system are being integrated and tested in Geneva. At the March
2017 investor presentations, AVO provided a revised timeline for completion of the
London Proton Therapy Centre, first patient treatments, and an update on its commercial
and financial strategies.

 
 **Strategy:** To develop a compact and modular proton therapy system at an affordable
price for the payor, financially attractive to the operator, whilst generating superior
patient outcomes. AVO benefits from the technology know-how developed by ADAM, Geneva
and relies on a base of world-class suppliers.

**Timeline:** A revised timeline has been provided showing a clear pathway for installation
of the first LIGHT system at Harley Street. Excavation work will commence by April
with construction expected to take 62-96 weeks, followed by fit-out.

**Key milestone achieved:** Meanwhile, the technical aspect is progressing at ADAM
with a key milestone announced at the Investor meeting on the 6th March 2017 – the
proton beam has been successfully fired through the RFQ at 5MeV, which is the exact
requirement of energy acceleration of this component.

**Partnership:** The relationship with Thales is the key driver of success for full
commercialisation of the LIGHT system. A facility for two production lines is being
developed at Thonon, bringing a manufacturing capacity of eight machines per year
when fully operational.

**Commercial:** The Harley street project is independent of the commercial success
of the LIGHT system, as it bears its own challenges. Independently of the timetable
of the Harley Street site, AVO is in active discussions with multiple partners, 
potential customers and distributors across the world.

**Risks:** Construction work in a listed area of London has some challenges. More
validation work is needed on the LIGHT system, which is mitigated by the know-how
of the ADAM team and the Thales partnership, and provides a strong base for commercialisation
of the technology. The main risk is that of execution.

**Investment summary:** Demand in Proton Therapy is increasing worldwide and the
need for a small, flexible, affordable and close-to-patient machine is desirable.
Advanced Oncotherapy Plc has attracted strong partners and discussions with potential
customers have already started. Attention is focused on the construction timetable
for the flagship Harley Street site and installation of the first LIGHT system. 
Resolution of its financing requirement is an important milestone.

Share on: